Table of Contents Author Guidelines Submit a Manuscript
Neural Plasticity
Volume 2013, Article ID 971817, 8 pages
http://dx.doi.org/10.1155/2013/971817
Research Article

Quality and Timing of Stressors Differentially Impact on Brain Plasticity and Neuroendocrine-Immune Function in Mice

1Section of Behavioural Neuroscience, Department of Cell Biology and Neurosciences, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy
2Section of Biomarkers in Degenerative Diseases, Department of Cell Biology and Neurosciences, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy

Received 23 January 2013; Revised 8 March 2013; Accepted 12 March 2013

Academic Editor: Alessandro Sale

Copyright © 2013 Sara Capoccia et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Cirulli, N. Francia, A. Berry, L. Aloe, E. Alleva, and S. J. Suomi, “Early life stress as a risk factor for mental health: role of neurotrophins from rodents to non-human primates,” Neuroscience and Biobehavioral Reviews, vol. 33, no. 4, pp. 573–585, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. E. R. De Kloet, R. H. DeRijk, and O. C. Meijer, “Therapy insight: is there an imbalanced response of mineralocorticoid and glucocorticoid receptors in depression?” Nature Clinical Practice Endocrinology and Metabolism, vol. 3, no. 2, pp. 168–179, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. K. S. Kendler, L. M. Karkowski, and C. A. Prescott, “Causal relationship between stressful life events and the onset of major depression,” American Journal of Psychiatry, vol. 156, no. 6, pp. 837–841, 1999. View at Google Scholar · View at Scopus
  4. B. S. McEwen, “The neurobiology of stress: from serendipity to clinical relevance,” Brain Research, vol. 886, no. 1-2, pp. 172–189, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. B. S. McEwen, “Protection and damage from acute and chronic stress: allostasis and allostatic overload and relevance to the pathophysiology of psychiatric disorders,” Annals of the New York Academy of Sciences, vol. 1032, pp. 1–7, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Eskandari and E. M. Sternberg, “Neural-immune interactions in health and disease,” Annals of the New York Academy of Sciences, vol. 966, pp. 20–27, 2002. View at Google Scholar · View at Scopus
  7. B. S. McEwen, “Central effects of stress hormones in health and disease: understanding the protective and damaging effects of stress and stress mediators,” European Journal of Pharmacology, vol. 583, no. 2-3, pp. 174–185, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Cirulli and E. Alleva, “The NGF saga: from animal models of psychosocial stress to stress-related psychopathology,” Frontiers in Neuroendocrinology, vol. 30, no. 3, pp. 379–395, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Tapia-Arancibia, F. Rage, L. Givalois, and S. Arancibia, “Physiology of BDNF: focus on hypothalamic function,” Frontiers in Neuroendocrinology, vol. 25, no. 2, pp. 77–107, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. G. S. Griesbach, J. Vincelli, D. L. Tio, and D. A. Hovda, “Effects of acute restraint-induced stress on glucocorticoid receptors and brain-derived neurotrophic factor after mild traumatic brain injury,” Neuroscience, vol. 210, pp. 393–402, 2012. View at Publisher · View at Google Scholar
  11. G. Naert, G. Ixart, T. Maurice, L. Tapia-Arancibia, and L. Givalois, “Brain-derived neurotrophic factor and hypothalamic-pituitary-adrenal axis adaptation processes in a depressive-like state induced by chronic restraint stress,” Molecular and Cellular Neuroscience, vol. 46, no. 1, pp. 55–66, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Cirulli, A. Berry, L. T. Bonsignore et al., “Early life influences on emotional reactivity: evidence that social enrichment has greater effects than handling on anxiety-like behaviors, neuroendocrine responses to stress and central BDNF levels,” Neuroscience and Biobehavioral Reviews, vol. 34, no. 6, pp. 808–820, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Thoenen, “Neurotrophins and neuronal plasticity,” Science, vol. 270, no. 5236, pp. 593–598, 1995. View at Google Scholar · View at Scopus
  14. R. M. Sapolsky, “Depression, antidepressants, and the shrinking hippocampus,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 22, pp. 12320–12322, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. R. S. Duman and L. M. Monteggia, “A neurotrophic model for stress-related mood disorders,” Biological Psychiatry, vol. 59, no. 12, pp. 1116–1127, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Castrén, V. Võikar, and T. Rantamäki, “Role of neurotrophic factors in depression,” Current Opinion in Pharmacology, vol. 7, no. 1, pp. 18–21, 2007. View at Publisher · View at Google Scholar
  17. F. D. Jeanneteau, W. M. Lambert, N. Ismaili et al., “BDNF and glucocorticoids regulate corticotrophin-releasing hormone (CRH) homeostasis in the hypothalamus,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 4, pp. 1305–1310, 2012. View at Publisher · View at Google Scholar
  18. L. Aloe, E. Alleva, A. Bohm, and R. Levi-Montalcini, “Aggressive behavior induces release of nerve growth factor from mouse salivary gland into the bloodstream,” Proceedings of the National Academy of Sciences of the United States of America, vol. 83, no. 16, pp. 6184–6187, 1986. View at Google Scholar · View at Scopus
  19. W. A. Nockher and H. Renz, “Neurotrophins in clinical diagnostics: pathophysiology and laboratory investigation,” Clinica Chimica Acta, vol. 352, no. 1-2, pp. 49–74, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Hayley, M. O. Poulter, Z. Merali, and H. Anisman, “The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity,” Neuroscience, vol. 135, no. 3, pp. 659–678, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. F. S. Dhabhar, “Enhancing versus suppressive effects of stress on immune function: implications for immunoprotection and immunopathology,” NeuroImmunoModulation, vol. 16, no. 5, pp. 300–317, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. M. A. Smith, S. Makino, R. Kvetnansky, and R. M. Post, “Effects of stress on neurotrophic factor expression in the rat brain,” Annals of the New York Academy of Sciences, vol. 771, pp. 234–239, 1995. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Barbany and H. Persson, “Regulation of neurotrophin mRNA expression in the rat brain by glucocorticoids,” European Journal of Neuroscience, vol. 4, no. 5, pp. 396–403, 1992. View at Publisher · View at Google Scholar · View at Scopus
  24. F. Marmigère, L. Givalois, F. Rage, S. Arancibia, and L. Tapia-Arancibia, “Rapid induction of BDNF expression in the hippocampus during immobilization stress challenge in adult rats,” Hippocampus, vol. 13, no. 5, pp. 646–655, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. B. S. Mcewen and P. J. Gianaros, “Central role of the brain in stress and adaptation: links to socioeconomic status, health, and disease,” Annals of the New York Academy of Sciences, vol. 1186, pp. 190–222, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. B. S. McEwen, C. A. Biron, K. W. Brunson et al., “The role of adrenocorticoids as modulators of immune function in health and disease: neural, endocrine and immune interactions,” Brain Research Reviews, vol. 23, no. 1-2, pp. 79–133, 1997. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Chiba, T. Numakawa, M. Ninomiya, M. C. Richards, C. Wakabayashi, and H. Kunugi, “Chronic restraint stress causes anxiety- and depression-like behaviors, downregulates glucocorticoid receptor expression, and attenuates glutamate release induced by brain-derived neurotrophic factor in the prefrontal cortex,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 39, no. 1, pp. 112–119, 2012. View at Publisher · View at Google Scholar
  28. L. K. Singh, X. Pang, N. Alexacos, R. Letourneau, and T. C. Theoharides, “Acute immobilization stress triggers skin mast cell degranulation via corticotropin releasing hormone, neurotensin, and substance P: a link to neurogenic skin disorders,” Brain, Behavior, and Immunity, vol. 13, no. 3, pp. 225–239, 1999. View at Publisher · View at Google Scholar · View at Scopus
  29. D. J. Nutt and D. J. Stein, “Understanding the neurobiology of comorbidity in anxiety disorders,” CNS Spectrums, vol. 11, no. 10, supplement 12, pp. 13–20, 2006. View at Google Scholar · View at Scopus
  30. J. F. Cryan and A. Holmes, “Model organisms: the ascent of mouse: advances in modelling human depression and anxiety,” Nature Reviews Drug Discovery, vol. 4, no. 9, pp. 775–790, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Berry, V. Bellisario, S. Capoccia, A. Calza, E. Alleva, and F. Cirulli, “Social deprivation stress is a triggering factor for the emergence of anxiety- and depression-like behaviours and leads to reduced brain BDNF levels in C57BL/6J mice,” Psychoneuroendocrinology, vol. 37, no. 6, pp. 762–772, 2012. View at Publisher · View at Google Scholar
  32. L. R. Frick, M. L. Palumbo, M. P. Zappia, M. A. Brocco, G. A. Cremaschi, and A. M. Genaro, “Inhibitory effect of fluoxetine on lymphoma growth through the modulation of antitumor T-cell response by serotonin-dependent and independent mechanisms,” Biochemical Pharmacology, vol. 75, no. 9, pp. 1817–1826, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. L. R. Frick, M. L. Barreiro Arcos, M. Rapanelli et al., “Chronic restraint stress impairs T-cell immunity and promotes tumor progression in mice,” Stress, vol. 12, no. 2, pp. 134–143, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. R. Avitsur, D. A. Padgett, and J. F. Sheridan, “Social interactions, stress, and immunity,” Neurologic Clinics, vol. 24, no. 3, pp. 483–491, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Avitsur, J. L. Stark, F. S. Dhabhar, K. A. Kramer, and J. F. Sheridan, “Social experience alters the response to social stress in mice,” Brain, Behavior, and Immunity, vol. 17, no. 6, pp. 426–437, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. F. Cirulli, M. L. Terranova, and G. Laviola, “Affiliation in periadolescent rats: behavioral and corticosterone response to social reunion with familiar or unfamiliar partners,” Pharmacology Biochemistry and Behavior, vol. 54, no. 1, pp. 99–105, 1996. View at Publisher · View at Google Scholar · View at Scopus
  37. J. B. Panksepp, K. A. Jochman, J. U. Kim et al., “Affiliative behavior, ultrasonic communication and social reward are influenced by genetic variation in adolescent mice,” PLoS ONE, vol. 2, no. 4, article e351, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. M. L. Terranova, G. Laviola, and E. Alleva, “Ontogeny of amicable social behavior in the mouse: gender differences and ongoing isolation outcomes,” Developmental Psychobiology, vol. 26, no. 8, pp. 467–481, 1993. View at Google Scholar · View at Scopus
  39. L. Aloe, F. Properzi, L. Probert et al., “Learning abilities, NGF and BDNF brain levels in two lines of TNF-α transgenic mice, one characterized by neurological disorders, the other phenotypically normal,” Brain Research, vol. 840, no. 1-2, pp. 125–137, 1999. View at Publisher · View at Google Scholar · View at Scopus
  40. C. E. Perandones, V. A. Illera, D. Peckham, L. L. Stunz, and R. F. Ashman, “Regulation of apoptosis in vitro in mature murine spleen T cells,” Journal of Immunology, vol. 151, no. 7, pp. 3521–3529, 1993. View at Google Scholar · View at Scopus
  41. A. H. Wyllie, J. F. R. Kerr, and A. R. Currie, “Cell death: the significance of apoptosis,” International Review of Cytology, vol. 68, pp. 251–306, 1980. View at Google Scholar · View at Scopus
  42. S. Bhatnagar, R. Huber, N. Nowak, and P. Trotter, “Lesions of the posterior paraventricular thalamus block habituation of hypothalamic-pituitary-adrenal responses to repeated restraint,” Journal of Neuroendocrinology, vol. 14, no. 5, pp. 403–410, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. O. Watters and J. J. O'Connor, “A role for tumor necrosis factor-alpha in ischemia and ischemic preconditioning,” Journal of Neuroinflammation, vol. 8, p. 87, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. M. J. Ehrke, S. Verstovšek, D. L. Maccubbin et al., “Protective specific immunity induced by doxorubicin plus TNF-α combination treatment of EL4 lymphoma-bearing C57BL/6 mice,” International Journal of Cancer, vol. 87, no. 1, pp. 101–109, 2000. View at Publisher · View at Google Scholar
  45. R. van Horssen, T. L. M. Ten Hagen, and A. M. M. Eggermont, “TNF-α in cancer treatment: molecular insights, antitumor effects, and clinical utility,” Oncologist, vol. 11, no. 4, pp. 397–408, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. M. J. Ehrke, S. Verstovsek, S. K. Pocchiari et al., “Thymic anti-tumor effectors in mice cured of lymphoma by cyclophosphamide plus TNF-α therapy: phenotypic and functional characterization up to 20 months after initial tumor inoculation,” International Journal of Cancer, vol. 76, no. 4, pp. 579–586, 1998. View at Publisher · View at Google Scholar
  47. C. A. Altar, “Neurotrophins and depression,” Trends in Pharmacological Sciences, vol. 20, no. 2, pp. 59–61, 1999. View at Publisher · View at Google Scholar · View at Scopus
  48. E. Castren, “Is mood chemistry?” Nature Reviews Neuroscience, vol. 6, no. 3, pp. 241–246, 2005. View at Google Scholar
  49. S. Sen, R. Duman, and G. Sanacora, “Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications,” Biological Psychiatry, vol. 64, no. 6, pp. 527–532, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. C. P. Reddy Avula, A. R. Muthukumar, K. Zaman, R. McCarter, and G. Fernandes, “Inhibitory effects of voluntary wheel exercise on apoptosis in splenic lymphocyte subsets of C57BL/6 mice,” Journal of Applied Physiology, vol. 91, no. 6, pp. 2546–2552, 2001. View at Google Scholar · View at Scopus